Emodin blocked TGF-β1 signaling pathways in breast cancer cells, both canonical and noncanonical, and decreased transcription factors essential for EMT and CSC, according to mechanistic investigations [119]. This evidence concerns the gene TGFB1 and breast carcinoma.